← Eichor
Study identifier: NCT07539038 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Condition: Breast Cancer  ·  Sponsor: Centro di Riferimento Oncologico - Aviano

PhaseN/A
Planned participants44
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life. This is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).

This description comes directly from the study's public registry record.

Talk to the study team

Mattia Garutti  ·  0434659092  ·  mattia.garutti@cro.it

Always discuss trial participation with your own doctor first.

Locations (1)

Centro di Riferimento Oncologico di AvianoAviano, Pordenone, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07539038